Interstitial lung disease in primary immunodeficiency: towards a brighter future

John R. Hurst, Klaus Warnatz

Source: Eur Respir J, 55 (4) 2000089; 10.1183/13993003.00089-2020
Journal Issue: April
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
John R. Hurst, Klaus Warnatz. Interstitial lung disease in primary immunodeficiency: towards a brighter future. Eur Respir J, 55 (4) 2000089; 10.1183/13993003.00089-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung disease in common variable immunodeficiency associated granulomatous disease
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Pulmonary diseases in primary immunodeficiency syndromes
Source: Respipedia Article
Year: 2017

Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

How could we objectively measure lung disease severity in children with severe combined immunodeficiency?
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005


Interstitial lung disease: the Japanese perspective
Source: International Congress 2017 – Ethnic differences and their clinical impact on respiratory diseases in Europe and Japan
Year: 2017


Humoral immunodeficiency and the lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=220
Year: 2005

The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010


A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Interstitial lung diseases: a clinical update
Source: Eur Respir J 2001; 18: 1S
Year: 2001


Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019


Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014


Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018


Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012